Cited by 1,465Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaPharmaceutical Economics and Policy

Access to effective antimicrobials: a worldwide challenge

Laxminarayan, Ramanan, Matsoso, Precious, Pant, Suraj, Brower, Charles, Røttingen, John-Arne, Klugman, Keith, Davies, Sally·2016·The Lancet

Abstract

Recent years have seen substantial improvements in life expectancy and access to antimicrobials, especially in low-income and lower-middle-income countries, but increasing pathogen resistance to antimicrobials threatens to roll back this progress. Resistant organisms in health-care and community settings pose a threat to survival rates from serious infections, including neonatal sepsis and health-care-associated infections, and limit the potential health benefits from surgeries, transplants, and cancer treatment. The challenge of simultaneously expanding appropriate access to antimicrobials, while restricting inappropriate access, particularly to expensive, newer generation antimicrobials, is unique in global health and requires new approaches to financing and delivering health care and a one-health perspective on the connections between pathogen transmission in animals and humans. Here, we describe the importance of effective antimicrobials. We assess the disease burden caused by limited access to antimicrobials, attributable to resistance to antimicrobials, and the potential effect of vaccines in restricting the need for antibiotics.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)00474-2

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Worldwide human consumption of antibiotics increased by 36% between 2000 and 2010.

    “Literature shows that worldwide human consumption of antibiotics increased by 36% between 2000 and 2010.10”

    From Consumption of systemic antibiotics in India in 2019 (2022) · cites this paper as [10]

  • Among BRICS countries, 23% of the retail sales volume was attributable to India, where regulations to control over-the-counter sales of antibiotics are poorly enforced.

    “Among these countries, 23% of the retail sales volume was attributable to India, where regulations to control over-the-counter sales of antibiotics are poorly enforced.”

    From Consumption of systemic antibiotics in India in 2019 (2022) · cites this paper as [10]

  • BRICS accounted for three-quarters of the increase in worldwide human consumption of antibiotics between 2000 and 2010 despite collectively representing only 40% of the world's population.

    “Brazil, Russia, India, China, and South Africa (BRICS) accounted for three-quarters of the increase despite collectively representing only 40% of the world's population.”

    From Consumption of systemic antibiotics in India in 2019 (2022) · cites this paper as [10]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S.
Affiliations
  • Princeton University (US)
  • Department of Health (ZA)
  • Center for Disease Dynamics, Economics & Policy (US)
  • Norwegian Institute of Public Health (NO)
  • Gates Foundation (US)
Corresponding author
Laxminarayan, Ramanan
Venue
The Lancet
Publisher
Elsevier BV
Published
2016-01
Volume
387
Issue
10014
Pages
168-175
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2180752973
Cited by
1,465
References
65
Citations by year
2026: 133 · 2025: 144 · 2024: 165 · 2023: 156 · 2022: 130 · 2021: 196 · 2020: 178 · 2019: 129 · 2018: 94 · 2017: 83 · 2016: 49 · 2015: 6
FWCI
6.74
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
antimicrobial resistance, antibiotic resistance, low-income countries, nosocomial infections, neonatal sepsis, One Health, disease burden, vaccines, health care financing, global health
MeSH terms
Animals, Animal Husbandry, Anti-Bacterial Agents, Developing Countries, Drug Resistance, Microbial, Health Services Accessibility, Humans, Meat, Pneumonia, Global Health, Sepsis, Developed Countries, Pneumococcal Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review